BioPorto (Denmark) Top Management
BIOPOR Stock | DKK 1.50 0.01 0.66% |
BioPorto employs about 31 people. The company is managed by 7 executives with a total tenure of roughly 73 years, averaging almost 10.0 years of service per executive, having 4.43 employees per reported executive. Analysis of BioPorto's management performance can provide insight into the company performance.
Christopher Bird Insider Chief Officer |
Neil CPA Insider Ex CFO |
BioPorto |
BioPorto Management Team Effectiveness
The company has return on total asset (ROA) of (0.4077) % which means that it has lost $0.4077 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8803) %, meaning that it generated substantial loss on money invested by shareholders. BioPorto's management efficiency ratios could be used to measure how well BioPorto manages its routine affairs as well as how well it operates its assets and liabilities.BioPorto Workforce Comparison
BioPorto is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 5,651. BioPorto maintains roughly 31.0 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of (2.5) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.82) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.82. BioPorto Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioPorto Price Series Summation is a cross summation of BioPorto price series and its benchmark/peer.
BioPorto Notable Stakeholders
A BioPorto stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioPorto often face trade-offs trying to please all of them. BioPorto's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioPorto's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Christopher Bird | Chief Officer | Profile | |
Neil CPA | Ex CFO | Profile | |
Jennifer Zonderman | VP Commercialization | Profile | |
Lars Uttenthal | Chief Officer | Profile | |
Gry Larsen | G Counsel | Profile | |
Nis Kruse | Ex APAC | Profile | |
Anthony Pare | Chief Officer | Profile |
About BioPorto Management Performance
The success or failure of an entity such as BioPorto often depends on how effective the management is. BioPorto management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioPorto management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioPorto management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioPorto AS, an in-vitro diagnostics company, provides diagnostic tests and antibodies for healthcare professionals in clinical and research settings worldwide. BioPorto AS was founded in 2000 and is headquartered in Hellerup, Denmark. BioPorto operates under Diagnostics Research classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 31 people.
Please note, the presentation of BioPorto's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioPorto's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioPorto's management manipulating its earnings.
BioPorto Workforce Analysis
Traditionally, organizations such as BioPorto use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioPorto within its industry.BioPorto Manpower Efficiency
Return on BioPorto Manpower
Revenue Per Employee | 782.4K | |
Revenue Per Executive | 3.5M | |
Net Loss Per Employee | 1.8M | |
Net Loss Per Executive | 8.2M | |
Working Capital Per Employee | 1.2M | |
Working Capital Per Executive | 5.3M |
Complementary Tools for BioPorto Stock analysis
When running BioPorto's price analysis, check to measure BioPorto's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioPorto is operating at the current time. Most of BioPorto's value examination focuses on studying past and present price action to predict the probability of BioPorto's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioPorto's price. Additionally, you may evaluate how the addition of BioPorto to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |